Silicon Valley, Calif., is a preeminent source of innovation, but money is tight and startups are hurting. In 2002, biotech and software companies
fared best both in new and follow-on funding. Tom Jacobs goes inside each of these two sides of the Valley. This week, nanobiotech.
fared best both in new and follow-on funding. Tom Jacobs goes inside each of these two sides of the Valley. This week, nanobiotech.
Link: fool.com
